Thyroglobulin, Comprehensive (With Anti-Tg Screen and Reflex to RIA) (Endocrine Sciences) TEST: 500540 CPT: 84432; 86800
2018/2019 ICD-10-CM Diagnosis Code R94.6. Abnormal results of thyroid function studies. 2016 2017 2018 2019 Billable/Specific Code. R94.6 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
Separate serum from cells, and transfer specimen to a plastic transport tube. Thyroglobulin antibody results should be interpreted in light of the total clinical presentation of the patient, including symptoms, clinical history, data from additional tests, and other appropriate information.
As with all two-site "sandwich" immunoassays, some of the analytical limitations of Tg IMA include hook effects, human mouse antibody (HAMA), and anti-Tg interference. The Access Thyroglobulin assay does not demonstrate any "hook" effect for concentrations up to 40,000 ng/mL.
ICD-10 Code for Abnormal results of thyroid function studies- R94. 6- Codify by AAPC.
E04. 1 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM E04.
ICD-10 code Z13. 29 for Encounter for screening for other suspected endocrine disorder is a medical classification as listed by WHO under the range - Factors influencing health status and contact with health services .
ICD-10 code R68. 89 for Other general symptoms and signs is a medical classification as listed by WHO under the range - Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified .
ICD-Code E03. 9 is a billable ICD-10 code used for healthcare diagnosis reimbursement of Hypothyroidism, Unspecified.
2.
Encounter for screening for lipoid disorders Z13. 220 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM Z13. 220 became effective on October 1, 2021.
Code R53. 83 is the diagnosis code used for Other Fatigue. It is a condition marked by drowsiness and an unusual lack of energy and mental alertness. It can be caused by many things, including illness, injury, or drugs.
APPENDIX CDiagnoses Currently Covered by Medicare for Serum TSH TestingICD-9-CM CodePersistent (P), Thyroid (T), or Short-term (S)?Diagnosis246.0–246.9TOther disorders of thyroid250.00–250.93PDiabetes mellitus252.1PHypoparathyroidismICD-9-CMPersistent (P), Thyroid (T), or Code Short-term (S)?Diagnosis153 more rows
R68. 89 is a VALID/BILLABLE ICD10 code, i.e it is valid for submission for HIPAA-covered transactions. R68. 89 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
From ICD-10: For encounters for routine laboratory/radiology testing in the absence of any signs, symptoms, or associated diagnosis, assign Z01. 89, Encounter for other specified special examinations.
NCD 190.15 In some patients presenting with certain signs, symptoms or diseases, a single CBC may be appropriate.
Encounter for screening for other diseases and disorders Screening is the testing for disease or disease precursors in asymptomatic individuals so that early detection and treatment can be provided for those who test positive for the disease.
Z13. 820 Encounter for screening for osteoporosis - ICD-10-CM Diagnosis Codes.
A screening colonoscopy should be reported with the following International Classification of Diseases, 10th edition (ICD-10) codes: Z12. 11: Encounter for screening for malignant neoplasm of the colon.
Z00.00ICD-10 Code for Encounter for general adult medical examination without abnormal findings- Z00. 00- Codify by AAPC.
Thyroglobulin (Tg) measurement is intended to aid in monitoring for the presence of orthotropic and/or metastatic thyroid tissues in patients who have had thyroid gland ablation ( using thyroid surgery with or without radioactivity). Measurement of thyroglobulin antibody (TgAb) is used to identify patient samples that may be affected by TgAb ...
If TgAb is negative, serum thyroglobulin is measured by a sensitive IMA with a relatively rapid turnaround time, generally two to three days. If TgAb is positive, serum thyroglobulin is measured by an RIA method. This RIA is resistant to interference by TgAb but has a turnaround time of five to seven days.
2. The effect of any thyroid injury caused by inflammation associated with thyroiditis; radioactive iodine (RAI) therapy; fine needle aspiration (FNA) biopsy; or surgery. 3.
The degree of TSH-receptor stimulation from endogenous TSH, recombinant human TSH (rhTSH), human chorionic gonadotropin (during pregnancy) or antibodies that stimulate the TSH receptor (Graves' disease). Measurement of serum Tg is used primarily in the postoperative management and long-term surveillance of patients with DTC.
Thyroglobulin (Tg) is synthesized exclusively by thyroid follicular cells as the precursor protein for thyroid hormone biosynthesis. 1,4,5 The serum Tg reflects the integrated sum of Tg released into the blood stream and is related to three factors:
This test may exhibit interference when sample is collected from a person who is consuming a supplement with a high dose of biotin (also termed as vitamin B7 or B8, vitamin H, or coenzyme R). It is recommended to ask all patients who may be indicated for this test about biotin supplementation.
Turnaround time is defined as the usual number of days from the date of pickup of a specimen for testing to when the result is released to the ordering provider. In some cases, additional time should be allowed for additional confirmatory or additional reflex tests. Testing schedules may vary.
Separate serum from cells, and transfer specimen to a plastic transport tube.
Thyroglobulin antibody results should be interpreted in light of the total clinical presentation of the patient, including symptoms, clinical history, data from additional tests, and other appropriate information.
The United States NHANES III survey reported a TgAb prevalence of approximately 10% for the general population, measured by competitive immunoassay. 1 This study reported that 3% of subjects with no risk factors for thyroid disease had detectable TgAb without associated presence of thyroid peroxidase (TPO) antibodies.
1. Hollowell JG, Staehling NW, Flanders WD, et al. Serum TSH,T (4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab. 2002 Feb; 87 (2):489-499. PubMed 11836274
Thyroglobulin Antibodies - Measurement of thyroglobulin antibodies is useful in the diagnosis and management of a variety of thyroid disorders including Hashimoto's thyroiditis, Graves' disease and certain types of goiter.
Please visit our Clinical Education Center to stay informed on any future publications, webinars, or other education opportunities.